Dr. Roger Sur

And that speaks to also the studies showing the use of ureteroscopy has grown increasingly. And simultaneously, the use of shockwave lithotripsy lithotripsy has declined. And whereas percutaneous surgery, it makes up more of a minority of the surgeries. It's still there available, but it's still kind of a background player reserved for larger stones.

And that speaks to also the studies showing the use of ureteroscopy has grown increasingly. And simultaneously, the use of shockwave lithotripsy lithotripsy has declined. And whereas percutaneous surgery, it makes up more of a minority of the surgeries. It's still there available, but it's still kind of a background player reserved for larger stones.

So that being said, ureteroscopy has become much more common And we thought, hey, we're going to break them up with the homium laser. And there's a new laser out there. And isn't that good enough? And then shouldn't we be done?

So that being said, ureteroscopy has become much more common And we thought, hey, we're going to break them up with the homium laser. And there's a new laser out there. And isn't that good enough? And then shouldn't we be done?

So that being said, ureteroscopy has become much more common And we thought, hey, we're going to break them up with the homium laser. And there's a new laser out there. And isn't that good enough? And then shouldn't we be done?

But what we found is that even though we break up these stones and hope that some of them will pass and remove some of the bigger pieces with fragments, we found that actually leaving pieces behind has been a problem.

But what we found is that even though we break up these stones and hope that some of them will pass and remove some of the bigger pieces with fragments, we found that actually leaving pieces behind has been a problem.

But what we found is that even though we break up these stones and hope that some of them will pass and remove some of the bigger pieces with fragments, we found that actually leaving pieces behind has been a problem.

Specifically, the Edge Consortium, which actually I'm a part of, we had a publication demonstrating that there were 20 to 40% complication rates associated with leaving stone fragments behind.

Specifically, the Edge Consortium, which actually I'm a part of, we had a publication demonstrating that there were 20 to 40% complication rates associated with leaving stone fragments behind.

Specifically, the Edge Consortium, which actually I'm a part of, we had a publication demonstrating that there were 20 to 40% complication rates associated with leaving stone fragments behind.

For example, if you left a fragment behind, you could end up in the ER, you could have sepsis, you might need a stent or even another ureteroscopy, sometimes being hospitalized or just, like I said, emergency visit. So there are definitely complications associated with leaving stones behind. And even though we have lasers and we're breaking them up and dusting them,

For example, if you left a fragment behind, you could end up in the ER, you could have sepsis, you might need a stent or even another ureteroscopy, sometimes being hospitalized or just, like I said, emergency visit. So there are definitely complications associated with leaving stones behind. And even though we have lasers and we're breaking them up and dusting them,

For example, if you left a fragment behind, you could end up in the ER, you could have sepsis, you might need a stent or even another ureteroscopy, sometimes being hospitalized or just, like I said, emergency visit. So there are definitely complications associated with leaving stones behind. And even though we have lasers and we're breaking them up and dusting them,

We're still not at where we want to be for the patients.

We're still not at where we want to be for the patients.

We're still not at where we want to be for the patients.

I think, you know, she and many of the thought leaders recognize there's this term out there called clinically insignificant residual fragments. It's an acronym that's used in the stone literature. They would say, well, they're just insignificant residual fragments of three to four millimeters or two millimeters. Well, I think she was astute to realize that No fragment actually is insignificant.

I think, you know, she and many of the thought leaders recognize there's this term out there called clinically insignificant residual fragments. It's an acronym that's used in the stone literature. They would say, well, they're just insignificant residual fragments of three to four millimeters or two millimeters. Well, I think she was astute to realize that No fragment actually is insignificant.

I think, you know, she and many of the thought leaders recognize there's this term out there called clinically insignificant residual fragments. It's an acronym that's used in the stone literature. They would say, well, they're just insignificant residual fragments of three to four millimeters or two millimeters. Well, I think she was astute to realize that No fragment actually is insignificant.